| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | N-acetylputrescine | 726 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | N-acetylputrescine | 747 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
| GC POSITIVE ION MODE | N-acetylputrescine | 1480 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 1571 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 1620 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 1849 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 1970 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2003 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2015 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
| GC POSITIVE ION MODE | N-acetylputrescine | 2398 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2585 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2643 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 2810 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | N-acetylputrescine | 2814 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 3085 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 3369 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 3466 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | N-acetylputrescine | 3906 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 3932 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 4049 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 4286 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 4423 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | N-acetylputrescine | 4738 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 5218 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | N-acetylputrescine | 5239 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 5579 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 5896 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 6104 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 6229 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 6638 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | N-acetylputrescine | 6798 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | N-acetylputrescine | 7234 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 7940 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 7999 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | N-acetylputrescine | 8574 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 8637 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 9542 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 9567 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
| GC POSITIVE ION MODE | N-acetylputrescine | 9657 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 10697 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 11112 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 11330 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 11478 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 14415 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 14704 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | N-acetylputrescine | 15201 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 16325 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 16440 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 16746 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 16900 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | N-acetylputrescine | 17773 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | N-acetylputrescine | 24403 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
| GC POSITIVE ION MODE | N-acetylputrescine | 24537 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 31110 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | N-acetylputrescine | 36169 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | N-acetylputrescine | 44321 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | N-acetylputrescine | 51674 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | N-acetylputrescine | 74864 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|